When Motion isn’t Managed, Confidence is Lost
The challenge
One of the greatest challenges in radiotherapy is managing respiratory motion. Tumors in the thoracic and upper abdomen can shift several millimeters during the breathing cycle. If left uncompensated, this motion compromises targeting accuracy, increases dose to surrounding healthy tissue and ultimately threatens treatment outcomes. Even with advanced technologies such as IGRT and SGRT, without rigorous QA, motion variability introduces uncertainty into every treatment delivered. Without efficient, reliable motion QA, clinicians spend more time managing risk instead of treating patients.
The solution
QUASAR Respiratory Motion Phantom 2.0 ( pRESP ) addresses these challenges directly. As a programmable breathing and tumor motion simulator it allows physicists to perform end-to-end QA on motion-guided RT systems under clinically realistic conditions.
The phantom features a body oval and accessories made from water and tissue equivalent materials, replacing acrylic, to more accurately replicate patient conditions. This upgrade delivers higher-fidelity QA results and reduces the gap between phantom testing and true clinical performance, empowering physicists to verify that their systems are not just functioning but performing at the standard required for modern motion-guided radiotherapy.